Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
STJ [NYSE]
St. Jude Medical Inc.
IndexS&P 500 P/E21.21 EPS (ttm)3.03 Insider Own2.20% Shs Outstand285.91M Perf Week-2.19%
Market Cap18.38B Forward P/E15.23 EPS next Y4.22 Insider Trans-1.33% Shs Float279.22M Perf Month7.56%
Income880.00M PEG2.05 EPS next Q1.03 Inst Own85.70% Short Float2.58% Perf Quarter0.00%
Sales5.61B P/S3.28 EPS this Y4.20% Inst Trans-0.10% Short Ratio4.09 Perf Half Y0.97%
Book/sh14.36 P/B4.48 EPS next Y6.03% ROA8.50% Target Price71.05 Perf Year15.01%
Cash/sh4.53 P/C14.20 EPS next 5Y10.35% ROE21.50% 52W Range54.80 - 71.58 Perf YTD5.03%
Dividend1.08 P/FCF26.03 EPS past 5Y19.80% ROI12.30% 52W High-10.22% Beta1.32
Dividend %1.68% Quick Ratio1.50 Sales past 5Y4.70% Gross Margin71.80% 52W Low17.28% ATR1.21
Employees16000 Current Ratio1.90 Sales Q/Q2.50% Oper. Margin18.40% RSI (14)54.04 Volatility1.56% 1.81%
OptionableYes Debt/Eq0.94 EPS Q/Q-8.90% Profit Margin15.70% Rel Volume0.93 Prev Close63.97
ShortableYes LT Debt/Eq0.75 EarningsOct 15 BMO Payout34.40% Avg Volume1.76M Price64.27
Recom2.10 SMA200.47% SMA503.26% SMA200-0.18% Volume1,646,906 Change0.47%
Oct-16-14Reiterated Stifel Buy $75 → $66
Oct-16-14Reiterated Canaccord Genuity Sell $51 → $47
Sep-30-14Initiated Needham Strong Buy $78
Jul-17-14Reiterated Canaccord Genuity Sell $47 → $51
Jul-17-14Reiterated Barclays Overweight $75 → $78
Jul-08-14Initiated CRT Capital Buy $80
Apr-17-14Reiterated Canaccord Genuity Sell $51 → $47
Feb-10-14Upgrade Stifel Hold → Buy $75
Jan-23-14Reiterated Canaccord Genuity Sell $40 → $51
Jan-16-14Reiterated Barclays Overweight $72 → $75
Jan-09-14Reiterated Barclays Overweight $65 → $72
Jan-07-14Upgrade RBC Capital Mkts Underperform → Sector Perform $44 → $64
Dec-16-13Reiterated Deutsche Bank Buy $60 → $64
Dec-11-13Reiterated Barclays Overweight $63 → $65
Oct-17-13Reiterated Canaccord Genuity Sell $40 → $42
Sep-23-13Reiterated Barclays Overweight $57 → $61
Jul-18-13Reiterated Barclays Overweight $48 → $57
May-28-13Downgrade Canaccord Genuity Hold → Sell
May-16-13Reiterated Mizuho Buy $48 → $54
Apr-18-13Reiterated Canaccord Genuity Hold $42 → $35
Nov-19-14 12:30PM  St. Jude Medical's CardioMEMS HF System Tests Positive Zacks
Nov-18-14 05:15PM  Data Shows the CardioMEMS HF System Significantly Reduced 30-Day Hospital Readmission Rates Business Wire
10:55AM  Medtronic Earnings In Line; Sales Guidance Up at Investor's Business Daily
Nov-13-14 03:27PM  How Did Medical Device Makers Become Poster Children for Obamacare Critics? at Forbes
Nov-11-14 01:04PM  ST JUDE MEDICAL INC Financials EDGAR Online Financials
Nov-06-14 07:08PM  10-Q for St. Jude Medical, Inc. Company Spotlight
Nov-05-14 12:00PM  Key Analyst Sees Upside in Medical Devices After Midterm Elections at 24/7 Wall St.
02:29AM  Seven Obamacare Bills That The New GOP Senate Majority Should Pass In 2015 at Forbes
Nov-04-14 05:12PM  ST JUDE MEDICAL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Oct-27-14 01:54PM  Health care stocks hitting new highs CNBC
08:00AM  St. Jude Medical Receives FDA Approval of TactiCath Quartz Contact Force Ablation Catheter for Treatment of Atrial Fibrillation Business Wire
Oct-21-14 05:11PM  St. Jude Medical Announces Fourth Quarter Dividend Business Wire
Oct-16-14 11:27AM  Why St Jude Medical (STJ) Stock Is Falling Today at TheStreet
Oct-15-14 01:07PM  St. Jude Medical lowers forecast; shares fall Reuters
12:43PM  Wednesday's midday movers: Boeing, Delta & more at CNBC
12:16PM  Why St. Jude Medical (STJ) Stock Is Declining Today at TheStreet
11:33AM  St Jude Medical (STJ) Earnings Report: Q3 2014 Conference Call Transcript at TheStreet
10:25AM  St. Jude Medical Beats on Q3 Earnings by a Penny Zacks
08:41AM  [$$] St. Jude Cuts Revenue Guidance at The Wall Street Journal
07:49AM  St.Jude Medical adjusted profit rises Reuters
07:39AM  St. Jude beats 3Q earnings expectations AP
07:37AM  ST JUDE MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
07:30AM  St. Jude Medical Reports Third Quarter 2014 Results Business Wire
07:07AM  Q3 2014 St. Jude Medical Inc Earnings Release - Before Market Open CCBN
Oct-13-14 09:04AM  Piper Jaffray Has Positive Outlook On St. Jude Medical Ahead Of 3Q14 Earnings Benzinga
08:20AM  Will St. Jude Medical (STJ) Disappoint this Earnings Season? Zacks
07:16AM  St. Jude draws bulls ahead of report optionMONSTER
Oct-06-14 07:40AM  Bank Of America Tweaks Numbers For St. Jude Medical, Inc. Lower On F/X, Portico Benzinga
Oct-01-14 04:20PM  St. Jude Medical Announces Third Quarter 2014 Earnings Conference Call Business Wire
Sep-30-14 07:47AM  Coverage initiated on St. Jude Medical by Needham Briefing.com
Sep-26-14 01:03PM  Today's Top Performers In Health Services at TheStreet
Sep-23-14 12:20PM  St. Jude Medical Gets CE Mark for Pacing Lead Labeling Zacks
11:24AM  [video] Jim Cramer's Take on Lew's Crackdown of Corporate Tax Inversions at TheStreet
Sep-22-14 08:30AM  St. Jude Medical Receives CE Mark Approval for Pacing Lead Labeling That Will Expand Patient Access to MRI Scans Business Wire
Sep-17-14 05:50PM  St. Jude Medical Comes Up with Positive CardioMEMS Data Zacks
02:20PM  St. Jude Medical Gets Clearance for PCI Optimization System Zacks
Sep-16-14 12:50PM  St. Jude Medical Gets Award for Leadless Pacemaker Again Zacks
Sep-15-14 08:30PM  CardioMEMS Data Shows Pulmonary Artery Pressure Monitoring Significantly Reduces Heart Failure Hospitalizations in Patients with Chronic Kidney Disease Business Wire
07:00PM  Cramer: Your move ahead of Alibaba CNBC
07:00PM  [video] Cramer: Your move ahead of Alibaba at CNBC
12:40PM  St. Jude Medical Reports Positive 12-Month EnligHTN Data Zacks
11:16AM  St. Jude Medical Announces Launch of OPTIS Integrated System Business Wire
09:00AM  St. Jude Medical Nanostim Leadless Pacemaker Receives Prestigious Award at the Annual Phoenix Conference Business Wire
Sep-13-14 05:01PM  Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients Business Wire
Sep-07-14 03:49PM  No More a Simple Distributor Gurufocus
Sep-03-14 12:20PM  Positive Data on St. Jude Medical Quadripolar Lead System Zacks
Sep-02-14 12:50PM  St. Jude Medical's Tech Helps Coronary Artery Patients Zacks
09:55AM  Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD Business Wire
Sep-01-14 02:42PM  New Clinical Trial Results Demonstrate Importance of St. Jude Medical Fractional Flow Reserve in Guiding Treatment of NSTEMI Patients Business Wire
Aug-31-14 04:11AM  Large-scale Study Confirms Growing Body of Clinical Evidence for the St. Jude Medical Quadripolar System Business Wire
Aug-28-14 04:20PM  St. Jude Medical to Present at the Morgan Stanley Global Healthcare Conference Business Wire
Aug-27-14 12:20PM  St. Jude Medical Settles FDA Warnings Letter for Texas Plant Zacks
Aug-26-14 04:28PM  St. Jude Medical Resolves FDA Warning Letter for Plano Facility Business Wire
06:00AM  Why St. Jude Medical Has Become a Must-Own Medical Device Stock at TheStreet
Aug-19-14 06:51PM  Lightning Round: EOG Resources, Verizon & more at CNBC
Aug-13-14 01:50PM  St. Jude Medical Completes Acquiring Pain Solutions Maker Zacks
Aug-07-14 04:05PM  Volcano Reports Second Quarter Results PR Newswire
08:00AM  St. Jude Medical Completes Acquisition of NeuroTherm Business Wire
Aug-05-14 08:00AM  CardioMEMS Heart Failure Monitoring System Receives Approval from CMS for New Technology Add-On Payment Business Wire
Aug-01-14 12:11PM  Wall Street Transcript Interview with Mark D. Perrin, the CEO of InVivo Therapeutics Corporation (NVIV) Wall Street Transcript
11:10AM  Obamacare Becomes a Long-Term Tailwind for Creating Value for Senior Housing REITs: A Wall Street Transcript Interview with Dana Hambly, CFA, Research Associate on the Health Care Services Team with Stephens Inc. Wall Street Transcript
Jul-30-14 05:10PM  ST JUDE MEDICAL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Jul-29-14 06:16PM  St. Jude Medical Announces Third Quarter Dividend Business Wire
Jul-25-14 12:17PM  Covidien Beats on Q3 Earnings but Revenues Miss Zacks
Jul-24-14 10:55PM  St. Jude Medical Gets CE Mark for FlexAbility Catheter Zacks
Jul-22-14 08:02AM  St. Jude announces FlexAbility Ablation Catheter CE Mark approval, first use theflyonthewall.com
08:00AM  St. Jude Medical Announces CE Mark Approval and First Use of the FlexAbility Ablation Catheter Business Wire
Jul-21-14 08:03PM  Jim Cramer's 'Mad Money' Recap: Don't Panic, Just Wait at TheStreet
11:14AM  Red Flags from Weekly Charts at Forbes
Jul-17-14 04:31PM  3 Key Takeaways From St. Jude Medical Stock's Earnings at Motley Fool
Jul-16-14 06:10PM  Abbott, St. Jude Top Views, But Stocks Under Pressure at Investor's Business Daily
05:03PM  St. Jude Medical, Inc. Still Feeling the Love at Motley Fool
03:39PM  St. Jude not keen to join inversion deal craze Reuters
01:58PM  St. Jude, Abbott Labs Earnings Beat Q2 Estimates at Investor's Business Daily
01:51PM  St. Jude Medical Conference Call Highlights Benzinga
01:02PM  Midday movers: Abbott, Northern Trust, Tesla & More at CNBC
12:35PM  St. Jude Medical (STJ) Stock Is Down Despite Positive Earnings Results at TheStreet
11:35AM  St. Jude Medical Beats on Q2 Earnings, Upgrades Outlook Zacks
08:58AM  Top Stocks to Watch Today: St. Jude Medical, Abbott Laboratories, Eli Lilly, Pfizer at Motley Fool
08:51AM  [$$] St. Jude Medical Profit More Than Doubles at The Wall Street Journal
08:42AM  St Jude Medical's quarterly profit doubles as expenses fall Reuters
07:37AM  ST JUDE MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
07:30AM  St. Jude Medical Reports Second Quarter 2014 Results Business Wire
07:07AM  Q2 2014 St. Jude Medical, Inc. Earnings Release - Before Market Open CCBN
Jul-15-14 01:50PM  St. Jude Medical to Acquire Chronic Pain Solutions Maker Zacks
09:44AM  St. Jude Medical Pays $200M for NeuroTherm at TheStreet
Jul-14-14 05:02PM  Here's What You Need to Know About Baxter International and St. Jude Medical's Upcoming Earnings at Motley Fool
10:06AM  [$$] St. Jude Medical to Buy NeuroTherm at The Wall Street Journal
09:05AM  St. Jude Medical to acquire NeuroTerm for approximately $200M in cash theflyonthewall.com
09:00AM  St. Jude Medical Announces Definitive Agreement to Acquire NeuroTherm Business Wire
Jul-13-14 06:21PM  Will earnings tell the story markets need to hear? at CNBC
Jul-09-14 12:10PM  St. Jude Medical Looks Attractive With Solid Returns Zacks
Jul-08-14 12:30PM  St. Jude Medical Hits New Lifetime High Zacks
Jul-07-14 09:45AM  Today St Jude Medical (STJ) Hits New Lifetime High at TheStreet
Jul-02-14 12:27PM  Midday movers: Delta, GoPro, Target & more at CNBC
08:49AM  FDA says manufacturing issues at St. Jude plant resolved Reuters
08:00AM  St. Jude Medical Resolves FDA Warning Letter for Sylmar Facility Business Wire
Jun-25-14 04:45PM  St. Jude Medical Announces Second Quarter 2014 Earnings Conference Call Business Wire
Jun-24-14 01:04AM  Boston's Watchman Under New FDA Scrutiny at Motley Fool
Jun-23-14 02:45PM  St. Jude Medical Hits New 52-Week High Zacks
St. Jude Medical, Inc. develops, manufactures and distributes medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies. The company offers tachycardia implantable cardioverter defibrillator systems that provide therapy to patients suffering from heart conditions, such as sudden cardiac arrest; and cardiac resynchronization therapy devices to treat patients suffering from heart failure. It also provides pacemakers for patients whose hearts beat too slowly or who suffer from other cardiac arrhythmias; leads to carry electrical impulses to the heart and provide information from the heart to the device; and programmers and remote monitoring equipment, which are used by physicians and healthcare professionals to program cardiac rhythm management devices and analyze device data to enhance patient management. In addition, the company offers vascular closure devices, compression assist devices, pressure measurement guidewires, diagnostic coronary imaging technology, vascular plugs, percutaneous catheter introducers, and diagnostic guidewires; and transcatheter aortic heart valves, heart valve repair and replacement products, and transcatheter structural heart defect devices. Further, it provides electrophysiology introducers and catheters, and ablation systems, as well as cardiac mapping, navigation, and recording systems for diagnosing and treating various irregular heart rhythms. Additionally, the company offers neurostimulation systems for chronic pain, such as rechargeable and primary cell implantable pulse generators. The company sells its products through direct sales force and independent distributors. St. Jude Medical, Inc. was founded in 1976 and is headquartered in Saint Paul, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fecho JeffVP, Global QualityJan 27Option Exercise35.277,075249,5358,912Jan 29 04:51 PM
Craig Angela DVP - Global Human ResourcesOct 30Option Exercise34.9620,000699,20024,941Nov 03 05:01 PM
Thome ScottVP, Global Ops & Supply ChainOct 30Option Exercise35.275,632198,6415,632Nov 03 05:01 PM
Ellingson RachelVP, Corporate RelationsOct 30Option Exercise37.795,369202,8977,463Nov 03 05:01 PM
Thome ScottVP, Global Ops & Supply ChainOct 30Sale64.225,632361,6870Nov 03 05:01 PM
Craig Angela DVP - Global Human ResourcesOct 30Sale64.1220,0001,282,4004,941Nov 03 05:01 PM
Ellingson RachelVP, Corporate RelationsOct 30Sale61.845,369332,0193,127Nov 03 05:01 PM
Zurbay DonaldVP Finance and CFOOct 29Option Exercise38.5938,0001,466,42051,740Oct 31 04:37 PM
Dallager JeffVP and Corporate ControllerOct 29Option Exercise36.9019,597723,09512,405Oct 31 04:36 PM
Zurbay DonaldVP Finance and CFOOct 29Sale61.7138,0002,344,98013,740Oct 31 04:37 PM
Dallager JeffVP and Corporate ControllerOct 29Sale61.6819,5971,208,7432,405Oct 31 04:36 PM
Fecho JeffVP, Global QualityOct 27Sale60.5550030,2751,452Oct 29 05:00 PM
Zellers JasonVP, General Counsel & Corp SecOct 23Option Exercise35.631,58456,4401,624Oct 27 04:45 PM
Zellers JasonVP, General Counsel & Corp SecOct 23Option Exercise35.1431,9991,124,47224,168Oct 27 04:45 PM
Zellers JasonVP, General Counsel & Corp SecOct 23Sale60.002,000120,000792Oct 27 04:45 PM
Zellers JasonVP, General Counsel & Corp SecOct 23Sale60.0431,9991,921,2205,502Oct 27 04:45 PM
STARKS DANIEL JChairman, CEO & PresidentOct 22Option Exercise30.58100,0003,058,0006,201,625Oct 24 04:34 PM
STARKS DANIEL JChairman, CEO & PresidentOct 22Sale60.04100,0006,004,0006,101,625Oct 24 04:34 PM
Andrade LisaVP and Chief Marketing OfficerOct 21Option Exercise38.004,000152,0007,841Oct 23 03:58 PM
Andrade LisaVP and Chief Marketing OfficerOct 21Sale60.004,000240,0003,841Oct 23 03:58 PM
Carlson MarkChief Medical Off-VP,ClinicalJul 30Sale66.401,19879,5472,853Jul 31 04:54 PM
Murphy Mark W.VP, IT and CIOJul 29Option Exercise34.962,00069,9204,473Jul 31 04:53 PM
STARKS DANIEL JChairman, CEO & PresidentJul 29Sale66.2590,0005,962,5006,101,625Jul 31 04:55 PM
Murphy Mark W.VP, IT and CIOJul 29Sale66.432,000132,8602,473Jul 31 04:53 PM
Gestin Denis MPresident, Int'l DivisionJul 28Option Exercise37.5899,0003,720,00060,757Jul 30 04:43 PM
Gestin Denis MPresident, Int'l DivisionJul 28Sale66.7699,0006,609,24010,757Jul 30 04:43 PM
Thome ScottVP, Global Ops & Supply ChainJul 18Option Exercise41.655,997249,7755,997Jul 22 04:50 PM
Fecho JeffVP, Global QualityJul 18Option Exercise39.057,099277,2324,837Jul 22 04:51 PM
Fecho JeffVP, Global QualityJul 18Sale66.737,099473,7161,837Jul 22 04:51 PM
Thome ScottVP, Global Ops & Supply ChainJul 18Sale67.065,997402,1590Jul 22 04:50 PM
DEVENUTI RICHARD RDirectorApr 28Option Exercise38.205,600213,92024,522Apr 30 05:44 PM
BROWN JOHN WDirectorApr 07Option Exercise38.205,600213,920130,465Apr 10 05:15 PM
Craig Angela DVP - Global Human ResourcesMar 04Option Exercise40.8445,5011,858,39738,807Mar 06 04:47 PM
Craig Angela DVP - Global Human ResourcesMar 04Sale68.0045,5013,094,0685,306Mar 06 04:47 PM
ROUSSEAU MICHAEL TChief Operating OfficerFeb 18Option Exercise30.5850,0001,529,00068,711Feb 21 08:11 AM
ROUSSEAU MICHAEL TChief Operating OfficerFeb 18Sale67.0850,0003,354,00018,711Feb 21 08:11 AM
ROCCA MICHAEL ADirectorFeb 06Option Exercise38.205,600213,92022,047Feb 10 05:14 PM
ROCCA MICHAEL ADirectorFeb 06Sale60.365,600338,01616,447Feb 10 05:14 PM
Thome ScottVP, Global Ops & Supply ChainFeb 05Option Exercise38.597,500289,4257,500Feb 07 04:54 PM
Thome ScottVP, Global Ops & Supply ChainFeb 05Sale59.577,500446,7750Feb 07 04:54 PM
ROUSSEAU MICHAEL TChief Operating OfficerFeb 04Sale59.764,644277,52520,382Feb 06 04:36 PM
Becker JoelPresident - USDJan 27Option Exercise42.7014,164604,7488,925Jan 29 04:48 PM
Fecho JeffVP, Global QualityJan 27Option Exercise34.963,333116,5225,170Jan 29 04:51 PM
Fecho JeffVP, Global QualityJan 27Sale61.2810,408637,8021,837Jan 29 04:51 PM
Becker JoelPresident - USDJan 27Sale61.5814,164872,2193,925Jan 29 04:48 PM
Murphy Mark W.VP, IT and CIOJan 24Option Exercise37.779,480358,0415,952Jan 28 05:22 PM
Murphy Mark W.VP, IT and CIOJan 24Sale63.149,480598,5671,614Jan 28 05:22 PM
Becker JoelPresident - USDDec 18Option Exercise35.1337,9161,332,13125,175Dec 20 04:46 PM
HEINMILLER JOHN CExecutive Vice PresidentDec 18Sale59.494,144246,532236,357Dec 20 04:45 PM
Becker JoelPresident - USDDec 18Sale59.5437,9162,257,5193,925Dec 20 04:46 PM
CALLAGHAN FRANK JPresident, CATDDec 16Option Exercise35.8470,6242,531,21624,735Dec 17 05:49 PM
CALLAGHAN FRANK JPresident, CATDDec 16Sale59.2873,8264,376,6931,533Dec 17 05:49 PM
STARKS DANIEL JChairman, CEO & PresidentDec 09Option Exercise51.91108,0005,606,2806,294,116Dec 11 05:09 PM